335 related articles for article (PubMed ID: 18848155)
1. Granulocyte colony-stimulating factor administration: adverse events.
D'Souza A; Jaiyesimi I; Trainor L; Venuturumili P
Transfus Med Rev; 2008 Oct; 22(4):280-90. PubMed ID: 18848155
[TBL] [Abstract][Full Text] [Related]
2. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
Tigue CC; McKoy JM; Evens AM; Trifilio SM; Tallman MS; Bennett CL
Bone Marrow Transplant; 2007 Aug; 40(3):185-92. PubMed ID: 17563736
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
[TBL] [Abstract][Full Text] [Related]
5. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone.
Arimura K; Inoue H; Kukita T; Matsushita K; Akimot M; Kawamata N; Yamaguchi A; Kawada H; Ozak A; Arima N; Te C
Haematologica; 2005 Mar; 90(3):ECR10. PubMed ID: 15753051
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells.
Becker PS; Wagle M; Matous S; Swanson RS; Pihan G; Lowry PA; Stewart FM; Heard SO
Biol Blood Marrow Transplant; 1997 Apr; 3(1):45-9. PubMed ID: 9209740
[TBL] [Abstract][Full Text] [Related]
7. The clinical applications of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation: a review.
Tabbara IA; Ghazal CD; Ghazal HH
Anticancer Res; 1996; 16(6B):3901-5. PubMed ID: 9042278
[TBL] [Abstract][Full Text] [Related]
8. Erythema exsudativum multiforme induced by granulocyte colony-stimulating factor in an allogeneic peripheral blood stem cell donor.
Mori T; Sato N; Watanabe R; Okamoto S; Ikeda Y
Bone Marrow Transplant; 2000 Jul; 26(2):239-40. PubMed ID: 10918440
[TBL] [Abstract][Full Text] [Related]
9. Acute iritis induced by granulocyte colony-stimulating factor used for mobilization in a volunteer unrelated peripheral blood progenitor cell donor.
Parkkali T; Volin L; Sirén MK; Ruutu T
Bone Marrow Transplant; 1996 Mar; 17(3):433-4. PubMed ID: 8704701
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
Heuft HG; Goudeva L; Blasczyk R
Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
[TBL] [Abstract][Full Text] [Related]
11. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
Pulsipher MA; Nagler A; Iannone R; Nelson RM
Pediatr Blood Cancer; 2006 Apr; 46(4):422-33. PubMed ID: 16411207
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors.
Shapira MY; Kaspler P; Samuel S; Shoshan S; Or R
Am J Hematol; 2003 May; 73(1):33-6. PubMed ID: 12701117
[TBL] [Abstract][Full Text] [Related]
13. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion.
Möhle R; Kanz L
Semin Hematol; 2007 Jul; 44(3):193-202. PubMed ID: 17631183
[TBL] [Abstract][Full Text] [Related]
15. Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature.
Veerappan R; Morrison M; Williams S; Variakojis D
Bone Marrow Transplant; 2007 Aug; 40(4):361-4. PubMed ID: 17563733
[TBL] [Abstract][Full Text] [Related]
16. [Paradoxical myelosuppression with granulocyte-stimulating factor (G-CSF) and simultaneous administration chemotherapy].
Sanz Ortiz J; Llamazares A; López-Vega JM
Med Clin (Barc); 1993 Sep; 101(7):276. PubMed ID: 7538188
[No Abstract] [Full Text] [Related]
17. Clinical studies of granulocyte colony stimulating factor (G-CSF).
Scarffe JH; Kamthan A
Cancer Surv; 1990; 9(1):115-30. PubMed ID: 1703454
[TBL] [Abstract][Full Text] [Related]
18. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.
Martino M; Console G; Dattola A; Callea I; Messina G; Moscato T; Massara E; Irrera G; Fedele R; Gervasi A; Bresolin G; Iacopino P
Bone Marrow Transplant; 2009 Aug; 44(3):163-8. PubMed ID: 19182833
[TBL] [Abstract][Full Text] [Related]
19. Double apheresis of peripheral blood stem cells in a single day in children mobilized by granulocyte colony-stimulating factor for transplantation.
Okamoto Y; Watanabe T; Watanabe H; Onishi T; Kawano Y
Pediatr Transplant; 2009 Jun; 13(4):440-3. PubMed ID: 18992065
[TBL] [Abstract][Full Text] [Related]
20. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
